| 1 |
35021019 | Trikafta Rescues CFTR and Lowers Monocyte P2X7R-induced Inflammasome Activation in Cystic Fibrosis. | 2022 Apr 1 |
2 |
| 2 |
35072914 | The Pro-tumor and Anti-tumor Effects of NLRP3 Inflammasome as a New Therapeutic Option for Colon Cancer: a Meta-analysis of Pre-clinical Studies. | 2022 Jan 24 |
1 |
| 3 |
35134386 | The P2X7 receptor as a new pharmacological target for retinal diseases. | 2022 Apr |
1 |
| 4 |
35510301 | Extracellular adenosine triphosphate induces IDO and IFNγ expression of human periodontal ligament cells through P2 X7 receptor signaling. | 2022 May 4 |
1 |
| 5 |
33462776 | Purinergic Signaling of ATP in COVID-19 Associated Guillain-Barré Syndrome. | 2021 Mar |
1 |
| 6 |
33504771 | P2X7 receptor signaling promotes inflammation in renal parenchymal cells suffering from ischemia-reperfusion injury. | 2021 Jan 27 |
2 |
| 7 |
33644066 | The P2X7 Receptor in Osteoarthritis. | 2021 |
2 |
| 8 |
33889073 | P2X7 Receptors in Neurodegeneration: Potential Therapeutic Applications From Basic to Clinical Approaches. | 2021 |
1 |
| 9 |
34512324 | Gallic Acid Alleviates Neuropathic Pain Behaviors in Rats by Inhibiting P2X7 Receptor-Mediated NF-κB/STAT3 Signaling Pathway. | 2021 |
1 |
| 10 |
32331389 | The P2X7 Receptor and NLRP3 Axis in Non-Alcoholic Fatty Liver Disease: A Brief Review. | 2020 Apr 22 |
1 |
| 11 |
32450899 | Blocking Connexin-43 mediated hemichannel activity protects against early tubular injury in experimental chronic kidney disease. | 2020 May 25 |
1 |
| 12 |
32486485 | P2X7 Receptor is Involved in Mitochondrial Dysfunction Induced by Extracellular Alpha Synuclein in Neuroblastoma SH-SY5Y Cells. | 2020 May 31 |
2 |
| 13 |
32577957 | Purinergic signaling as a basis of acupuncture-induced analgesia. | 2020 Sep |
1 |
| 14 |
32640257 | Sensing of ATP via the Purinergic Receptor P2RX7 Promotes CD8+ Trm Cell Generation by Enhancing Their Sensitivity to the Cytokine TGF-β. | 2020 Jul 14 |
1 |
| 15 |
32848594 | The P2X7 Receptor: Central Hub of Brain Diseases. | 2020 |
1 |
| 16 |
32892231 | The P2X7 purinergic receptor: a potential therapeutic target for lung cancer. | 2020 Nov |
2 |
| 17 |
32906646 | Amyloid Beta Peptide (Aβ1-42) Reverses the Cholinergic Control of Monocytic IL-1β Release. | 2020 Sep 7 |
1 |
| 18 |
33089283 | [Expression level and effect of P2X7 receptor mRNA during osteogenic differentiation of human periodontal ligament stem cells]. | 2020 Aug |
5 |
| 19 |
33105696 | Human P2X7 Receptor Causes Cycle Arrest in RPMI-8226 Myeloma Cells to Alter the Interaction with Osteoblasts and Osteoclasts. | 2020 Oct 22 |
1 |
| 20 |
30733317 | Preclinical Evaluation and Nonhuman Primate Receptor Occupancy Study of 18F-JNJ-64413739, a PET Radioligand for P2X7 Receptors. | 2019 Aug |
3 |
| 21 |
23328492 | Adenosine, adenosine receptors and glaucoma: an updated overview. | 2013 Apr |
1 |
| 22 |
21233486 | P2X7 receptor drives osteoclast fusion by increasing the extracellular adenosine concentration. | 2011 Apr |
1 |
| 23 |
19241145 | The P2X(7) receptor in retinal ganglion cells: A neuronal model of pressure-induced damage and protection by a shifting purinergic balance. | 2009 Jun |
2 |
| 24 |
18923921 | The P2X(7) receptor in retinal ganglion cells: A neuronal model of pressure-induced damage and protection by a shifting purinergic balance. | 2008 Dec |
2 |
| 25 |
16805847 | Balance of purines may determine life or death of retinal ganglion cells as A3 adenosine receptors prevent loss following P2X7 receptor stimulation. | 2006 Jul |
1 |